Dr. Evian Gordon
BSc (Hons), PhD, Chairman

Dr. Gordon has over 30 years experience in human brain research.  He was the director of the Brain Dynamics Centre at Westmead Hospital and a senior lecturer in the Department of Psychological Medicine at the University of Sydney.  He edited the book “Integrative Neuroscience” and has more than 200 publications.

Matt Mund
Interim CEO/Managing Director

Matt is an executive leader with proven accomplishments in corporate strategy, product development, business operations. Expertise across a wide range of functional and leadership roles including Strategy, Operations, Product and Marketing. Most recently served as EVP, Chief Product and Marketing Officer at Monster, and COO, Total Brain.

Matthew Morgan
MBA, Non-Executive Director

Matthew Morgan is the Principal of Millers Point Company, an advisory firm focused on emerging growth companies. He is a former venture capitalist at QIC and is Australia’s first Kauffman Fellow. He was a co-founder of Diversa Ltd (ASX DVA) which was sold to OneVue (ASX OVH) and serves as Chairman of Sensera Ltd (ASX SE1) and as a Non Executive Director and Chairman of the Audit and Risk Committee of Leaf Resources Ltd (ASX LER)

David Torrible
Non-Executive Director

Mr. Torrible is an active non-executive director and advisor to private companies, financial firms and charities since 2012 when he retired as a partner of Goldman Sachs. Prior to 2012 he worked 19 years as an equity specialist serving institutional accounts in Asian capital markets. He has worked in Hong Kong, Indonesia, USA and Australia. He is experienced in relationship management, capital market risk and successfully managing geographically diverse teams. Appointed as a director on June 1, 2019.

David Daglio
Non-Executive Director

David is an advisor to public companies, private companies, and charities and has over 30 years of business experience in corporate America. As an investor, David refined an investment approach that considered human behavior (as well as other factors) and how it affected investment decisions and stock prices. He and his teams of investors have studied thousands of financial models and then built upon years of intuition and common sense to forecast security prices and financial statements. As an advisor, he has worked with three investment firms: Mellon, The Boston Company, and X BK.